| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.600 | None | 0.957 | 46 | 4 | 1993 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.590 | None | 1.000 | 13 | 0 | 1996 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.590 | None | 1.000 | 13 | 0 | 1996 | 2019 | ||||||||
|
glycine N-methyltransferase | 0.626 | 0.462 | 2.8E-03 |
|
disease | 0.560 | None | 1.000 | 8 | 0 | 1998 | 2019 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
disease | 0.560 | None | 1.000 | 8 | 1 | 2007 | 2018 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.550 | None | 1.000 | 8 | 0 | 1999 | 2019 | ||||||||
|
transforming growth factor alpha | 0.432 | 0.885 | 0.72 |
|
disease | 0.550 | None | 1.000 | 7 | 0 | 1996 | 2014 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.540 | None | 1.000 | 6 | 0 | 1988 | 2007 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.530 | None | 1.000 | 4 | 0 | 1998 | 2017 | ||||||||
|
nuclear receptor subfamily 1 group H member 4 | 0.513 | 0.808 | 9.4E-04 |
|
disease | 0.520 | None | 1.000 | 10 | 0 | 2000 | 2018 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.520 | None | 1.000 | 5 | 0 | 1993 | 2020 | ||||||||
|
asparagine synthetase (glutamine-hydrolyzing) | 0.595 | 0.692 | 9.4E-06 |
|
disease | 0.510 | None | 1.000 | 3 | 0 | 1976 | 2019 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.510 | None | 1.000 | 2 | 0 | 2016 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 53 | 0 | 1999 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 23 | 1 | 2003 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 1.000 | 13 | 0 | 2008 | 2019 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 1.000 | 12 | 0 | 2004 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.390 | None | 1.000 | 10 | 0 | 2005 | 2020 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.380 | None | 1.000 | 8 | 0 | 2010 | 2019 | ||||||||
|
metastasis associated lung adenocarcinoma transcript 1 | 0.435 | 0.846 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 2012 | 2018 | |||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
disease | 0.360 | None | 1.000 | 7 | 0 | 2006 | 2018 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.350 | None | 1.000 | 6 | 0 | 2004 | 2019 | ||||||||
|
Jun proto-oncogene, AP-1 transcription factor subunit | 0.442 | 0.885 | 6.0E-02 |
|
disease | 0.340 | None | 1.000 | 6 | 0 | 2002 | 2017 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2008 | 2019 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.340 | None | 1.000 | 5 | 0 | 2004 | 2019 |